Clinical Trials Directory

Trials / Completed

CompletedNCT01638624

The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury

The Effect of Propofol Infusion on Total Antioxidant Status During Tourniquet-Induced Ischemia-Reperfusion Injury in Total Knee Arthroplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Diskapi Teaching and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The release of tourniquet produces reactive oxygen species which can cause injury. Propofol is chemically similar to phenol-based free radical scavengers. Plasma total antioxidant capacity is a well-established marker of the overall protective effect of antioxidants in body fluids.The aim of the study is to investigate the effects of propofol on ischemia-reperfusion injury in total knee arthroplasty (TKA).

Conditions

Interventions

TypeNameDescription
DRUGPropofolPropofol :Propofol is an anesthetic agent, has structure similar to that of known such as alfa tocopherol.
DRUGPlacebo

Timeline

Start date
2012-06-01
Primary completion
2012-10-01
Completion
2012-11-01
First posted
2012-07-12
Last updated
2016-06-13

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01638624. Inclusion in this directory is not an endorsement.